Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Saccharomyces Boulardii wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Chaga and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
1-3g dried mushroom or 500-1500mg extract daily
Morning, Can be taken as tea or with food
Dual extraction (hot water + alcohol) extract
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
4-8 weeks
4-8 weeks
2-4 weeks
During use
1-3 days
1-2 weeks
Medicinal Mushrooms in Colon Cancer Therapy: Mechanisms of Action of Bioactive Compounds and Therapeutic Potential
International journal of molecular sciences (2025) · Systematic review
Therefore, there is a strong demand for innovative, affordable, and minimally invasive treatments such as medicinal mushrooms.
Effects and mechanisms of natural products on Alzheimer's disease
Critical reviews in food science and nutrition (2023) · Systematic review
Alzheimer's disease (AD) is the most common form of dementia in elderly people with a high incidence rate and complicated pathogenesis, and causes progressive cognitive deficit and memory impairment.
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection
Nutrients (2020) · Systematic review
Thus, the possibilities of natural substances as effective treatments against COVID-19 may seem promising.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Evidence limited to systematic reviews without specific RCTs. Effects may vary significantly by extraction method - dual extracts likely more bioavailable than raw powder. Most studies are preclinical or mechanistic.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Saccharomyces Boulardii has a higher evidence score (8.5/10 vs 3.5/10) and wins in 3 of 3 categories.
For reduce inflammation, Saccharomyces Boulardii has a higher relevance score (90 vs 55).
No known interactions between Chaga and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.